{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T07:18:25Z","timestamp":1791962305900,"version":"4.3.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,6,22]],"date-time":"2016-06-22T00:00:00Z","timestamp":1466553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,6,22]],"date-time":"2016-06-22T00:00:00Z","timestamp":1466553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Plasma cell dyscrasias, including monoclonal gammopathy of undetermined significance (MGUS), multiple myeloma (MM), Waldenstr\u00f6m macroglobulinemia (WM) and light chain AL amyloidosis, are characterized by clonal expansion of plasma cells which produce a vast amount of an immunoglobulin-derived M-protein. We noted that MGUS diagnosis often coincided with diagnoses of senile cataract and glaucoma and tested the associations of MGUS, MM, WM and AL amyloidosis with subsequent eye diseases identified from the Swedish patient registers between 1997 and 2012. Standardized incidence ratios (SIRs) for senile cataract was significantly increased to 1.80 after MGUS, 1.70 after MM, 1.85 after WM and 2.31 after AL amyloidosis. The SIR for glaucoma was 1.60 after MGUS, 1.76 after WM and 2.18 after AL amyloidosis. All SIRs decreased systematically from age below 60 years to over 79 years, but most risks were also significant in age group over 79 years. The M-protein and the related increase in blood viscosity could be a novel etiologic discovery for these common eye diseases. As MGUS prevalence is around 3% at 60 years and close to 10% at age over 80 years, its contribution to the eye disease burden is expected to be remarkably high.<\/jats:p>","DOI":"10.1038\/srep28500","type":"journal-article","created":{"date-parts":[[2016,6,22]],"date-time":"2016-06-22T22:13:27Z","timestamp":1466633607000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The Incidence of Senile Cataract and Glaucoma is Increased in Patients with Plasma Cell Dyscrasias: Etiologic Implications"],"prefix":"10.1038","volume":"6","author":[{"given":"Kari","family":"Hemminki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asta","family":"F\u00f6rsti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raimo","family":"Tuuminen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto","family":"Hemminki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Goldschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Sundquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Sundquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,22]]},"reference":[{"key":"BFsrep28500_CR1","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1080\/09286580902737532","volume":"16","author":"RJ Glynn","year":"2009","unstructured":"Glynn, R. J., Rosner, B. & Christen, W. G. Evaluation of risk factors for cataract types in a competing risks framework. Ophthalmic Epidemiol 16, 98\u2013106 (2009).","journal-title":"Ophthalmic Epidemiol"},{"key":"BFsrep28500_CR2","doi-asserted-by":"crossref","unstructured":"Kapetanakis, V. V. et al. Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): a systematic review and meta-analysis. Br J Ophthalmol (2015).","DOI":"10.1136\/bjophthalmol-2015-307223"},{"key":"BFsrep28500_CR3","doi-asserted-by":"publisher","first-page":"e339","DOI":"10.1016\/S2214-109X(13)70113-X","volume":"1","author":"RR Bourne","year":"2013","unstructured":"Bourne, R. R. et al. Causes of vision loss worldwide, 1990\u20132010: a systematic analysis. Lancet Glob Health 1, e339\u201349 (2013).","journal-title":"Lancet Glob Health"},{"key":"BFsrep28500_CR4","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3109\/09286586.2015.1056537","volume":"22","author":"T Hamano","year":"2015","unstructured":"Hamano, T. et al. Neighborhood Deprivation and Risk of Age-Related Eye Diseases: A Follow-up Study in Sweden. Ophthalmic Epidemiol 22, 308\u201320 (2015).","journal-title":"Ophthalmic Epidemiol"},{"key":"BFsrep28500_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.maturitas.2013.01.018","volume":"75","author":"VB Voleti","year":"2013","unstructured":"Voleti, V. B. & Hubschman, J. P. Age-related eye disease. Maturitas 75, 29\u201333 (2013).","journal-title":"Maturitas"},{"key":"BFsrep28500_CR6","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S0140-6736(05)70803-5","volume":"365","author":"PA Asbell","year":"2005","unstructured":"Asbell, P. A. et al. Age-related cataract. Lancet 365, 599\u2013609 (2005).","journal-title":"Lancet"},{"key":"BFsrep28500_CR7","doi-asserted-by":"publisher","first-page":"Orsf54","DOI":"10.1167\/iovs.13-12940","volume":"54","author":"JM Petrash","year":"2013","unstructured":"Petrash, J. M. Aging and age-related diseases of the ocular lens and vitreous body. Invest Ophthalmol Vis Sci 54, Orsf54\u20139 (2013).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFsrep28500_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pbiomolbio.2014.02.004","volume":"115","author":"KJ Lampi","year":"2014","unstructured":"Lampi, K. J., Wilmarth, P. A., Murray, M. R. & David, L. L. Lens beta-crystallins: the role of deamidation and related modifications in aging and cataract. Prog Biophys Mol Biol 115, 21\u201331 (2014).","journal-title":"Prog Biophys Mol Biol"},{"key":"BFsrep28500_CR9","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1056\/NEJMra0804630","volume":"360","author":"YH Kwon","year":"2009","unstructured":"Kwon, Y. H., Fingert, J. H., Kuehn, M. H. & Alward, W. L. Primary open-angle glaucoma. N Engl J Med 360, 1113\u201324 (2009).","journal-title":"N Engl J Med"},{"key":"BFsrep28500_CR10","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2014.3192","volume":"311","author":"RN Weinreb","year":"2014","unstructured":"Weinreb, R. N., Aung, T. & Medeiros, F. A. The pathophysiology and treatment of glaucoma: a review. Jama 311, 1901\u201311 (2014).","journal-title":"Jama"},{"key":"BFsrep28500_CR11","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/leu.2015.279","volume":"30","author":"C Frank","year":"2016","unstructured":"Frank, C. et al. Search for familial clustering of multiple myeloma with any cancer Leukemia 30, 627\u201332 (2016).","journal-title":"Leukemia"},{"key":"BFsrep28500_CR12","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1038\/leu.2014.208","volume":"28","author":"N Weinhold","year":"2014","unstructured":"Weinhold, N. et al. Immunoglobulin light-chain amyloidosis shares genetic susceptibility with multiple myeloma. Leukemia 28, 2254\u20136 (2014).","journal-title":"Leukemia"},{"key":"BFsrep28500_CR13","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1182\/blood-2013-10-532283","volume":"123","author":"N Weinhold","year":"2014","unstructured":"Weinhold, N. et al. Inherited genetic susceptibility to monoclonal gammopathy of unknown significance. Blood 123, 2513\u20137 (2014).","journal-title":"Blood"},{"key":"BFsrep28500_CR14","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/leu.2010.60","volume":"24","author":"RA Kyle","year":"2010","unstructured":"Kyle, R. A. et al. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia 24, 1121\u20137 (2010).","journal-title":"Leukemia"},{"key":"BFsrep28500_CR15","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1056\/NEJMra1011442","volume":"364","author":"A Palumbo","year":"2011","unstructured":"Palumbo, A. & Anderson, K. Multiple myeloma. N Engl J Med 364, 1046\u201360 (2011).","journal-title":"N Engl J Med"},{"key":"BFsrep28500_CR16","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1182\/blood-2013-05-505487","volume":"123","author":"I Turesson","year":"2014","unstructured":"Turesson, I. et al. Monoclonal gammopathy of undetermined significance and risk of lymphoid and myeloid malignancies: 728 cases followed up to 30 years in Sweden. Blood 123, 338\u201345 (2014).","journal-title":"Blood"},{"key":"BFsrep28500_CR17","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/S0140-6736(10)60482-5","volume":"375","author":"A Dispenzieri","year":"2010","unstructured":"Dispenzieri, A. et al. Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study. Lancet 375, 1721\u20138 (2010).","journal-title":"Lancet"},{"key":"BFsrep28500_CR18","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/leu.2013.344","volume":"28","author":"GJ Morgan","year":"2014","unstructured":"Morgan, G. J. et al. Inherited genetic susceptibility to multiple myeloma. Leukemia 28, 518\u201324 (2014).","journal-title":"Leukemia"},{"key":"BFsrep28500_CR19","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1182\/blood-2008-12-191676","volume":"114","author":"O Landgren","year":"2009","unstructured":"Landgren, O. et al. Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden. Blood 114, 791\u20135 (2009).","journal-title":"Blood"},{"key":"BFsrep28500_CR20","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.mayocp.2012.06.014","volume":"87","author":"TM Therneau","year":"2012","unstructured":"Therneau, T. M. et al. Incidence of monoclonal gammopathy of undetermined significance and estimation of duration before first clinical recognition. Mayo Clin Proc 87, 1071\u20139 (2012).","journal-title":"Mayo Clin Proc"},{"key":"BFsrep28500_CR21","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1055\/s-2003-44554","volume":"29","author":"J Mehta","year":"2003","unstructured":"Mehta, J. & Singhal, S. Hyperviscosity syndrome in plasma cell dyscrasias. Semin Thromb Hemost 29, 467\u201371 (2003).","journal-title":"Semin Thromb Hemost"},{"key":"BFsrep28500_CR22","first-page":"265","volume":"26","author":"AE Omoti","year":"2007","unstructured":"Omoti, A. E. & Omoti, C. E. Ophthalmic manifestations of multiple myeloma. West Afr J Med 26, 265\u20138 (2007).","journal-title":"West Afr J Med"},{"key":"BFsrep28500_CR23","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/sj.eye.6701923","volume":"20","author":"GT Higgins","year":"2006","unstructured":"Higgins, G. T., Olujohungbe, A. & Kyle, G. Recurrent subconjunctival and periorbital haemorrhage as the first presentation of systemic AL amyloidosis secondary to myeloma. Eye (Lond) 20, 512\u20135 (2006).","journal-title":"Eye (Lond)"},{"key":"BFsrep28500_CR24","doi-asserted-by":"publisher","first-page":"854","DOI":"10.3324\/haematol.2011.054015","volume":"97","author":"SY Kristinsson","year":"2012","unstructured":"Kristinsson, S. Y. et al. Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study. Haematologica 97, 854\u20138 (2012).","journal-title":"Haematologica"},{"key":"BFsrep28500_CR25","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1158\/1055-9965.EPI-13-0695","volume":"23","author":"CM McShane","year":"2014","unstructured":"McShane, C. M. et al. Prior autoimmune disease and risk of monoclonal gammopathy of undetermined significance and multiple myeloma: a systematic review. Cancer Epidemiol Biomarkers Prev 23, 332\u201342 (2014).","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BFsrep28500_CR26","doi-asserted-by":"crossref","unstructured":"Landgren, O. et al. Agent Orange Exposure and Monoclonal Gammopathy of Undetermined Significance: An Operation Ranch Hand Veteran Cohort Study. JAMA Oncol (2015).","DOI":"10.1001\/jamaoncol.2015.2938"},{"key":"BFsrep28500_CR27","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1182\/blood-2010-04-282848","volume":"116","author":"SY Kristinsson","year":"2010","unstructured":"Kristinsson, S. Y. et al. Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study. Blood 116, 2651\u20135 (2010).","journal-title":"Blood"},{"key":"BFsrep28500_CR28","doi-asserted-by":"publisher","first-page":"4991","DOI":"10.1182\/blood-2009-11-252072","volume":"115","author":"SY Kristinsson","year":"2010","unstructured":"Kristinsson, S. Y. et al. Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study. Blood 115, 4991\u20138 (2010).","journal-title":"Blood"},{"key":"BFsrep28500_CR29","doi-asserted-by":"publisher","first-page":"685","DOI":"10.4065\/84.8.685","volume":"84","author":"JP Bida","year":"2009","unstructured":"Bida, J. P. et al. Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients. Mayo Clin Proc 84, 685\u201393 (2009).","journal-title":"Mayo Clin Proc"},{"key":"BFsrep28500_CR30","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.brainresbull.2009.09.015","volume":"81","author":"A Surguchev","year":"2010","unstructured":"Surguchev, A. & Surguchov, A. Conformational diseases: looking into the eyes. Brain Res Bull 81, 12\u201324 (2010).","journal-title":"Brain Res Bull"},{"key":"BFsrep28500_CR31","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1097\/IJG.0000000000000053","volume":"24","author":"LJ Jeang","year":"2015","unstructured":"Jeang, L. J., Chang, P. T. & Frankfort, B. J. Rapidly progressing glaucoma associated with monoclonal gammopathy. J Glaucoma 24, e139\u201341 (2015).","journal-title":"J Glaucoma"},{"key":"BFsrep28500_CR32","unstructured":"dos Santos Silva, I. Cancer Epidemiology: Principles and Methods, 442 (IARC, Lyon, 1999)."},{"key":"BFsrep28500_CR33","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.1182\/blood-2011-05-355743","volume":"118","author":"S Mailankody","year":"2011","unstructured":"Mailankody, S. et al. Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS). Blood 118, 4086\u201392 (2011).","journal-title":"Blood"},{"key":"BFsrep28500_CR34","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1186\/1471-2458-12-974","volume":"12","author":"K Hemminki","year":"2012","unstructured":"Hemminki, K., Li, X., Forsti, A., Sundquist, J. & Sundquist, K. Incidence and survival in non-hereditary amyloidosis in Sweden. BMC Public Health 12, 974 (2012).","journal-title":"BMC Public Health"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep28500.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep28500","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep28500.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T05:15:07Z","timestamp":1672895707000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep28500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,22]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,6,30]]}},"alternative-id":["BFsrep28500"],"URL":"https:\/\/doi.org\/10.1038\/srep28500","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,22]]},"assertion":[{"value":"1 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28500"}}